Search
Dr. Kathy Ku is vice president at Vive Collective, a venture capital firm focused on digital health. Kathy is an entrepreneur, an engineer and a former consultant. She holds an MD/MBA from Stanford, where she was a recipient of the Paul and Daisy Soros Fellowship, and an AB/SM from Harvard, where she studied engineering sciences and molecular and cellular biology.
The president-elect says RFK Jr. will help protect Americans from "pollutants, pesticides, pharmaceutical products and food additives."
In a letter to the FDA, members of Congress cite confusion over providers' deployment of clinical decision support software that is exempt from medical device regulations and call for clarity from its Center for Devices and Radiological Health.
The former GOP congressman from Georgia has served as a U.S. Navy chaplain and is a colonel in the Air Force Reserve. He would inherit a major EHR modernization initiative, currently paused but slated to restart in 2025, among other IT imperatives.
The U.S. Department of Homeland Security sees three areas of concern as artificial intelligence is used across critical infrastructure sectors: attacks using AI, attacks targeting AI systems and design, and implementation failures.
The agency is proposing telehealth access grants to establish fixed, secure environments outfitted with reliable internet and secure video that connect veterans hobbled by the digital divide to health services.
For Global Health Equity Week, Knight Consulting principal and New Jersey HIMSS member Mike Relli, describes how Section 1115 waivers can help states boost access and reduce SDOH disparities for citizens reentering the community after incarceration.
The Administration for Strategic Preparedness and Response will be surveying agencies to assess the readiness of state, local, tribal and territorial public health organizations to manage cyber threats and gauge their needs for support.
From preoperative planning and intraoperative guidance to visualization and predictive analytics, AI has many new roles to play to help surgeons do their best work.
Approximately 10% of all U.S. healthcare workers will divert opioids or other controlled substances from their workplace at some point in their career.1 Drug diversion, or the illegal distribution or abuse of prescription drugs, remains a top challenge at hospitals and health systems across the country, and is often undiscovered and underreported.2